^
Association details:
Biomarker:Chr amplification(11p)
Cancer:Non Small Cell Lung Cancer
Regimen:CaT
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

Cellworks Omics Biology Model (CBM) to identify amplifications of chromosome 11p and 1p predict paclitaxel and carboplatin resistance

Published date:
05/19/2021
Excerpt:
In NSCLC…of the 22 patients treated with PC, 13 had clinical responses and 9 were non-responders….novel amplified segments of Chromosome 11p and 1p were responsible for non-responsiveness to PC.
DOI:
10.1200/JCO.2021.39.15_suppl.e21208